Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.

Jane E Rogers,Lianchun Xiao,Allison Trail,Mariela Blum Murphy, Melissa Palmer,Jaffer A Ajani

Oncology（2020）

引用 8|浏览18

暂无评分

摘要

In this small cohort of patients, we conclude that this combination is quite feasible and resulted in prolonged stability in some patients. Further development of this regimen is warranted.

查看译文

关键词

Advanced gastric cancer,Esophageal neoplasms,Irinotecan,Nivolumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要